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Tlie Prevention of Recurrent Peritoneal Adhesions
A Clinical and Laboratory

Investigation

T. A. Cromwell, M.D.* and Joseph L . Ponka, M.D.*

This study documented the fact that recurrent episodes of small bowel obstruction
were not uncommon (38%) in a review of 120 patients who underwent lysis of
adhesions or lysis of adhesions and Noble Plication. A laboratory
experiment
using dogs was constructed to compare dextran to a combined
promethazinedexamethasone regimen for the prevention of adhesion formation in the immediate
post-operative period. Dextran was completely ineffective in preventing
adhesion
reformation.
Meticulous surgical technique remains the single most
important
factor in adhesion
prevention.

Small bowel obstruction from peritoneal adhesions continues to be a
threat to every patient undergoing abdominal surgery, with treatment of the
post-operative complication of intestinal obstruction less than ideal.
In a review of 120 records covering
a four-year period at Henry Ford Hospital, we found the initial operation
(see Fig 1) to be pelvic-gynecologic in
54 patients, appendectomy in 18 patients, colectomy in 14 patients, gastric resection in 10 patients and
cholecystectomy in 6 patients. In the
miscellaneous group of 18 patients,
11 had various procedures: ventral hernia repair, aneurysmectomy, small
bowel resection, etc. Five patients had
'••Fourth Surgical Division, Department of
Surgery
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INTESTIMAL OBSTRUCTION
Initial Operations
120 Patients

Patients
Pelvic-Gynecologic
Appendectomies
Colectomy
Gastric Resection
Cholecystectomies
Miscellaneous

54
18
14
10

6
18

45
15
12
8
5
15

Figure 1
intraabdominal inflammatory processes
and two patients had congenital bands.
In concurrence with other studies,*' ®
small bowel obstructions appeared
usually within two years after surgery
in patients developing severe peritonitis following colectomy and gastrectomy. Obstruction after pelvic surgery
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presented 12 to 15 years postoperatively.
Forty of the 120 patients were
treated non-operatively. Of the 80
others, 65 had lysis of adhesions and
15 had lysis of adhesions plus a Noble
plication. Thirty-one of the 80 patients
operated (38%) had recurrent episodes
of small bowel obstruction. This includes six patients in the Noble plication group (Fig 2).
INTESTINAL OBSTRUCTION
Type of Operation
80 Patients

Lysis of Adhesions
Noble Plication

Patients
65
15

Rec.
Obst.
25
6

"Recurrent Obstruction

Figure 2
Discussion
Adhesion formation is a result of
two basic processes, fibrin formation
and inflammation. Fibrin deposition,
as in blood coagulation, occurs on the
serosal surface of the bowel wall. The
extrinsic clotting mechanism is activated with tissue thromboplastin. Prothrombin is converted to thrombin
which converts fibrinogen to fibrin.
Both dicumerol and heparin have been
used successfully in experiments to decrease adhesion formation, but both
have been discarded because of undesirable bleeding.*^'
Once adjacent
serosal surfaces become fibrin coated
and adherent, the inflammatory process matures from exudation (fibrin
included) to fibroplasia and organization.
Prevention of adhesions lies with
gentle, careful surgical technique.

Early stimulation of peristalsis has
been found h e l p f u l . T h e many pharmacologic agents studied fall within
four broad groups: anticoagulants,
fibrinolytic agents, anti-inflammatory
agents, and macromolecular agents. We
compared dextran with the combined
promethazine-dexamethasone
therapy
outlined by Replogle, lohnson and
Gross in 1965."
Dextran is a bacterial polysaccharide
produced by leuconostoc mesentoides
with molecular weight ranging from
20,000 to 110,000. Theoretically, dextran would help prevent adhesions by
lubricating the serosal surfaces; it
would separate the bowel wall mechanically by creating an artificial ascites,
and, by coating the injured serosal surface with a nonpolar substance, should
help to maintain its electrical neutrality.
The antithrombotic effect of dextran in
patients is definite but dependent upon
dose, weight of dextran, and state of the
recipient's coagulation mechanism.*
The anti-thrombotic effect of high
molecular weight dextran in dogs is
due to a decrease in platelets, factor 5,
8 and fibrinogen.-' Also, since dextran
is relatively non-toxic, it is useful in
patients where more potent drugs are
contraindicated.
Laboratory Studies
In an attempt to improve our management of complicated adhesions, we
toolc this problem to the laboratory.
We created peritoneal adhesions in
dogs by abrading 50 cms of the terminal ileum with a firm brush. Two
weeks later the adhesions were lysed
and the animal treated as scheduled.
Two weeks after treatment, the animal
was reoperated and the extent of adhesions documented. Six groups with
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cal promise and success in other animal
s t u d i e s , ^ might be attributed to
the severity of the test and accelerated
absorption of dextran through the
damaged microcirculation of the peritoneum. An average 25-pound dog received 250 cc of high molecular weight
dextran intraperitoneally and intravenously at the time of surgery without
reflecting any major fluid shifts, as
measured by pre- and post-operative
sodium and hemoglobin values. There
was no effect on the degree of adhesion
formation in three dogs receiving intravenous high molecular weight dextran
for 24 hours post-operatively to
achieve a systemic anticoagulant effect
with a prolonged partial thromboplastin
time.

five dogs in each group were studied.
(Fig 3). The following protocol was
used:
Grade 0 Complete absence of adhesions.
Grade 1 A single, thin, easily separated adhesion.
Grade 2 Weak adhesions which
withstand traction poorly.
Grade 3 Numerous extensive tense
adhesions.
Grade 4 Grade 3 adhesions with
visceroparietal extension.
PLAN OF INVESTIGATION
GROUP
I

LYSIS OF ADHESIONS AND:
Lactated Ringers (LR) I.V. and
I.P. lOcc/lb.

II

Low molecular weight dextran I. P.

III

LMWD I.P. and I.V. lOcc/lb.

IV

HMWD I.P. and L.R. I.V. 10 cc/lb.

V

HMWD I.P. and I.V. 10 cc/lb.

VI

Steroid and antihistamine I. M.
I mg./kg.

and L.R. I.V. lOcc/lb.

The antihistaminic and steroid actions are synergistic. Steroid treatment
alone for this purpose is nothing new
and was used clinically in the late
Fifties on the basis of its antiinflammatory action.- Antihistaminic agents
minimize the early phase of inflammation by blocking the release of histamine from the mast cell. Histamine
increases vascular permeability, allowing an exudate to form. It also protects
the cellular lysosome system from a
variety of insults.

Figure 3
Dextran, in any form, was no more
effective than lactated Ringer's solution in preventing recurrent peritoneal
adhesions, using this particular experimental model (Fig 4). However, the
dexamethasone-promethazine
combination significantly decreased the degree of adhesion recurrence. The failure of dextran, in spite of its theoreti-

Conclusions
Our efforts have convinced us that
careful surgical technique remains the
backbone of adhesion prevention.
Trauma to the bowel wall must be kept
at a minimum by gentle handling. Dry
sponges and dry packs must not be
used and drying the serosal surfaces
by exposure to lights and air must be
avoided. Meticulous aseptic technique
and careful hemostasis must be maintained. The omentum should be pre-

RESULTS
Group
1
II
II
IV
V
VI

L-R(IP+1V)
LMWD (IP)
LMWD (1P•^IV)
HMWD (IP)
HMWD (IP IV)
Steroid •^ Antihist.
(IM + IP)

Dogs
4
4
4
4
4
4

Controls
4
above
above
above
above
above

Adhesion
A+

4•^
3•^
4•^
3-^
1+

Figure 4
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served when possible, and large raw
surfaces reperitonealized.
For the patient who continues to
present with recurrent small bowel obstruction from peritoneal adhesions, we

suggest surgical lysis of adhesions plus
promethazine-dexamethasone therapy.
This combination was most effective
in minimizing, but not eradicating, adhesions in the laboratory animal.
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